MYLUNG
Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 7,500 patients (estimated)
- Sponsors
- US Oncology Research, US Oncology Research
- Trial Type
- Observational
- Last Update
- 10 months ago
- SparkCures ID
- 1709
- NCT Identifier
- NCT05885698
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.